Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): An immunogenetic, serologic, and clinical analysis

Arthritis and Rheumatism

Volumn 39, Issue 7, 1996, Pages 1151-1160

  Arnett, Frank C ^c,h   Reveille, John D ^c   Goldstein, Rose ^b,d   Pollard, K Michael ^e   Leaird, Kimberly ^f   Smith, Edwin A ^f   LeRoy, E Carwile ^f   Fritzler, Marvin J ^a,g  

^a ALBERTA ENVIRONMENT AND PARKS   (Canada)

^b Arthritis Society   (Canada)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF CALGARY   (Canada)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN;

ANTIBODY DETECTION; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA TYPING; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SYSTEMIC SCLEROSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AUTOANTIBODIES; BASE SEQUENCE; CHROMOSOMAL PROTEINS, NON-HISTONE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, MHC CLASS II; HAPLOTYPES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NORTH AMERICA; SCLERODERMA, SYSTEMIC; STATISTICS;

EID: 0030015175     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390712     Document Type: Article

References (55)

1. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C: Diversity of antinuclear antibodies in progressive systemic sclerosis: anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23:617-625, 1980
2. Bernstein RM, Steigerwald JC, Tan EM: Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol 48:43-51, 1982
3. Riboldi P, Asero R, Origgi L, Crespi S, Meroni PL, Sguotti C, Sabbadini MG: Antinuclear antibodies in progressive systemic sclerosis. Clin Exp Rheumatol 3:205-211, 1985
4. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM: Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31:525-532, 1988
5. Kipnis RJ, Craft J, Hardin JA: The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum 33:1431-1437, 1990
6. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M: Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37:75-83, 1994
7. Reimer G, Scheer U, Peters JM, Tan EM: Immunolocalization and partial characterization of a nucleolar autoantigen (Pm-Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol 137:3802-3808, 1986
8. Ge Q, Wu Y, Trieu EP, Targoff IN: Analysis of the specificity of anti-PM-Scl autoantibodies. Arthritis Rheum 37:1445-1452, 1994
9. Reddy R, Tan EM, Henning D, Nohga K, Busch H: Detection of a nucleolar 7-2 ribonucleoprotein and a cytoplasmic 8-2 ribonucleoprotein with autoantibodies from patients with scleroderma. J Biol Chem 258:1383-1386, 1983
10. Okano Y, Medsger TA Jr: Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis. Arthritis Rheum 33:1822-1828, 1990
11. Rheimer G, Rose KM, Scheer U, Tan EM: Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest 79:65-72, 1987
12. Lischwe MA, Ochs RL, Reddy R, Cook RG, Yeoman LC, Tan EM, Reichlin M, Busch H: Purification and partial characterization of a nucleolar scleroderma antigen (Mr = 34,000;pl, 8.5) rich in Ng,Ng-dimethylarginine. J Biol Chem 260:14304-14310, 1985
13. Kass S, Tyc K, Steitz JA, Sollner-Webb B: The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell 60:897-908, 1990
14. Okano Y, Steen VD, Medsger TA Jr: Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 35:95-100, 1992
15. Weiner ES, Earnshaw WC, Senécal J-L, Bordwell B, Johnson P, Rothfield NF: Clinical associations of anticentromere antibodies and antibodies to topoisomerase I: a study of 355 patients. Arthritis Rheum 31:378-385, 1988
16. Hietarinta M, Tertti R, Lassila O: A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies. Clin Exp Rheumatol 11:457-461, 1993
17. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr: Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 37:902-906, 1994
18. Kurzhals G, Meurer M, Krieg T, Reimer G: Clinical association of autoantibodies to fibrillarin with diffuse scleroderma and disseminated telangiectasia. J Am Acad Dermatol 23:832-836, 1990
19. Robinson CJ, Balazs T, Egorov IK: Mercuric chloride-, gold sodium thimalate-, and D-penicillamine-induced antinuclear antibodies in mice. Toxicol Appl Pharmacol 86:159-169, 1986
20. Hultman P, Enestrom S, Pollard KM, Tan EM: Anti-fibrillarin autoantibodies in mercury-treated mice. Clin Exp Immunol 78: 470-472, 1989
21. Hultman P, Bell LJ, Enestrom S, Pollard KM: Murine susceptibility to mercury I. autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 65:98-109, 1992
22. 2-induced antinucleolar antibodies. Eur J Immunol 12:2257-2261, 1989
23. Warfvinge K, Hansson H, Hultman P: Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol Appl Pharmacol 132:299-309, 1995
24. Hultman P, Enestrom S, Turley SJ, Pollard KM: Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice. Clin Exp Immunol 96:285-291, 1994
25. Hultman P, Enestrom S: Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits. Clin Exp Immunol 71:269-274, 1988
26. Arnett FC: HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol 12:107-128, 1995
27. Masi AT, Rodnan GP, Medsger TA Jr, Altman RD, D'Angelo WA, Fries JF, LeRoy EC, Kirsner AB, MacKenzie AH, McShane DJ, Myers AR, Sharp GC: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
28. Park MS, Tonai R: Phenotype frequencies of the class II (DR, DQ) DNA alleles by the patterns of sequence-specific primer mixtures (SSPM) in four different populations and the probable haplotypes between DRB1 allele and DQB1. In, Clinical Transplants. Edited by PI Terasaki, JM Cecka. Los Angeles, UCLA Tissue Typing Laboratory, 1992
29. Fritzler MJ, Tan EM: Antinuclear antibodies and the connective tissue diseases. In, Laboratory Diagnostic Procedures in the Rheumatic Diseases. Edited by AS Cohen. New York, Grune and Stratton, 1985
30. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
31. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350-4354, 1979
32. Fritzler MJ: Autoantibody testing: procedures and significance in systemic rheumatic diseases, methods and achievements in experimental pathology. In, Methods and Achievements in Experimental Pathology. Edited by G Jasmin, R Simard. New York, S. Karger, 1986
33. Turley SJ, Tan EM, Pollard KM: Molecular cloning and sequence analysis of U3 snRNA-associated mouse fibrillarin. Biochim Biophys Acta 1216:119-122, 1993
34. Fritzler MJ, Hamel JC, Ochs RL, Chan EKL: Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex. J Exp Med 178:49-62, 1993
35. Reveille JD, Durban E, MacLeod MJ, Goldstein R, Moreda R, Altman RD, Arnett FC: Association of amino acid sequences in the HLA-DQB1 first domain with the anti-topoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 90:973-980, 1992
36. Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC, Arnett FC: Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 31:496-505, 1988
37. Olsen ML, Arnett FC, Reveille JD: Contrasting molecular patterns of MHC class II alleles associated with the Anti-Sm and Anti-RNP autoantibodies in systemic lupus erythematosus. Arthritis Rheum 36:94-104, 1993
38. Reed E, Ho E, Lupu F, McManus P, Vasilescu R, Foca-Rodi A, Suciu-Foca N: Polymorphism of HLA in the Romanian population. Tissue Antigens 39:8-13, 1992
39. Kocova M, Blagoevska M, Bogoevski M, Konstantinova M, Dorman J, Trucco M: HLA class II molecular typing in an European Slavic population with a low incidence of insulin-dependent diabetes mellitus. Tissue Antigens 45:216-219, 1995
40. Cerna M, Fernandez-Vina M, Ivaskova E, Stastny P: Comparison of HLA class II alleles in Gypsy and Czech populations by DNA typing. Tissue Antigens 39:111-116, 1992
41. Marintchev LM, Naumova EJ, Rashkov RK, Arnett FC, Reveille JD: HLA-class II alleles and autoantibodies in Bulgarians with systemic lupus erythematosus. Tissue Antigens 46:422-425, 1995
42. Reveille JD, Arnett FC, Olsen ML, Sakkas LP, Papasteriades C, Moutsopoulos HM: HLA-class II alleles and C4 null genes in Greeks with systemic lupus erythematosus. Tissue Antigens 46: 417-421, 1995
43. Reveille JD, Arnett FC: Frequencies of scleroderma-related autoantibodies in patients meeting the American College of Rheumatology criteria for systemic sclerosis: reply (letter). Arthritis Rheum 36:1333, 1993
44. Picillo U, Migliaresi S, Vatti M, Marcialis MR, Ferruzzi AM, Tirri G: Demographic differences in the frequencies of scleroderma-related autoantibodies (letter). Arthritis Rheum 36:1332-1333, 1993
45. McNeilage LJ, Youngchaiyud U, Whittingham S: Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32:54-60, 1989
46. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H: Survival with systemic sclerosis (scleroderma). Ann Intern Med 75:369-376, 1971
47. Altman RD, Medsger TA Jr, Bloch DA, Michel BA: Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403-413, 1991
48. Reveille JD, Owerbach D, Goldstein R, Moreda R, Isern RA, Arnett FC: Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 89: 1208-1213, 1992
49. Morel PA, Chang HJ, Wilson JW, Conte C, Falkner D, Tweardy DJ, Medsger TA Jr: HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol 42:35-42, 1995
50. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K: The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 92:1296-1301, 1993
51. Okano Y, Steen VD, Medsger TA Jr: Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119:1005-1013, 1993
52. Marguerie C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, So AK, Walport MJ: The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine (Baltimore) 71:327-336, 1992
53. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M: Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest 91:1399-1404, 1993
54. B cDNA clones. Proc Natl Acad Sci U S A 83:3594-3598, 1986
55. Gregersen PK, Todd JA, Erlich HA, Long E, Servenius B, Choi E, Kao HT, Lee JS: First domain diversity of DR and DQ subregion alleles. In, Immunobiology of HLA. Edited by B Dupont. New York, Springer-Verlag, 1989